Cashu
Soleno Therapeutics Faces Lawsuit Over Safety Concerns for Prader-Willi Syndrome Drug DCCR.
3 days ago
Stocks
Health Care
slno
Soleno Therapeutics
NASDAQ: SLNO
+12.77 (+32.34%)
52.26
USD
At close at Apr 06, 20:41 UTC
Latest Soleno Therapeutics News
prnewswire.com
SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Soleno Therapeutics, Inc. (NASDAQ: SLNO)
about 5 hours ago
prnewswire.com
Shareholder Alert: The Ademi Firm investigates whether Soleno Therapeutics Inc.'s Transaction with Neurocrine is Fair to Public Shareholders
about 8 hours ago
prnewswire.com
Neurocrine to Acquire Soleno Therapeutics, Expanding Its Endocrinology and Rare Disease Portfolio
about 12 hours ago
benzinga.com
Apellis Stock Soars After Biogen Deal, Momentum Score Surges—Here's What Shareholders Get
about 12 hours ago
benzinga.com
Why Applied Optoelectronics Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket
about 13 hours ago
prnewswire.com
Soleno Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - SLNO
about 14 hours ago
prnewswire.com
SLNO Investors Have Opportunity to Lead Soleno Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm
about 15 hours ago
prnewswire.com
SLNO Investors Have Opportunity to Lead Soleno Therapeutics, Inc. Securities Fraud Lawsuit
about 23 hours ago
prnewswire.com
Soleno Therapeutics, Inc. (SLNO) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
3 days ago
prnewswire.com
Soleno Therapeutics, Inc. Class Action Lawsuit: Investors Face May 5, 2026, Deadline
4 days ago
Join our newsletter to keep up to date with us!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.